The Age of Blood Evaluation randomised controlled trial (ABLE): Description of the UK funded arm of the international trial, the UK cost-utility analysis, and secondary analyses exploring factors associated with health-related quality of life and healthcare costs during 12 month follow-up

the ABLE-UK investigators

doi:10.3310/hta21620

The Age of Blood Evaluation randomised controlled trial (ABLE): Description of the UK funded arm of the international trial, the UK cost-utility analysis, and secondary analyses exploring factors associated with health-related quality of life and healthcare costs during 12 month follow-up

the ABLE-UK investigators

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	Health Technology Assessment
Volume	21
Issue number	62
DOIs	https://doi.org/10.3310/hta21620
Publication status	Published - 31 Oct 2017

Access to Document

10.3310/hta21620

3011361Final published version, 7.8 MB

THE AGE OF BLOOD EVALUATION STUDY (ABLE)
Walsh, T. & Murray, G.
Other
1/09/11 → 31/07/16
Project: Research

Timothy Walsh
- Deanery of Molecular, Genetic and Population Health Sciences - Chair of Critical Care
- Usher Institute
Person: Academic: Research Active

Cite this

the ABLE-UK investigators (2017). The Age of Blood Evaluation randomised controlled trial (ABLE): Description of the UK funded arm of the international trial, the UK cost-utility analysis, and secondary analyses exploring factors associated with health-related quality of life and healthcare costs during 12 month follow-up. Health Technology Assessment, 21(62). https://doi.org/10.3310/hta21620

the ABLE-UK investigators. / The Age of Blood Evaluation randomised controlled trial (ABLE) : Description of the UK funded arm of the international trial, the UK cost-utility analysis, and secondary analyses exploring factors associated with health-related quality of life and healthcare costs during 12 month follow-up. In: Health Technology Assessment. 2017 ; Vol. 21, No. 62.

@article{5011f861a76c4a8bb610d087ece9e995,

title = "The Age of Blood Evaluation randomised controlled trial (ABLE): Description of the UK funded arm of the international trial, the UK cost-utility analysis, and secondary analyses exploring factors associated with health-related quality of life and healthcare costs during 12 month follow-up",

author = "{the ABLE-UK investigators} and Tim Walsh and Simon Stanworth and Julia Boyd and David Hope and Sue Hemmatpour and Helen Burrows and Helen Campbell and Elena Pizzo and Nicholas Swart and Stephen Morris",

year = "2017",

month = oct,

day = "31",

doi = "10.3310/hta21620",

language = "English",

volume = "21",

journal = "Health Technology Assessment",

issn = "1366-5278",

publisher = "NIHR Health Technology Assessment Programme",

number = "62",

}

the ABLE-UK investigators 2017, 'The Age of Blood Evaluation randomised controlled trial (ABLE): Description of the UK funded arm of the international trial, the UK cost-utility analysis, and secondary analyses exploring factors associated with health-related quality of life and healthcare costs during 12 month follow-up', Health Technology Assessment, vol. 21, no. 62. https://doi.org/10.3310/hta21620

The Age of Blood Evaluation randomised controlled trial (ABLE): Description of the UK funded arm of the international trial, the UK cost-utility analysis, and secondary analyses exploring factors associated with health-related quality of life and healthcare costs during 12 month follow-up. / the ABLE-UK investigators.
In: Health Technology Assessment, Vol. 21, No. 62, 31.10.2017.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - The Age of Blood Evaluation randomised controlled trial (ABLE)

T2 - Description of the UK funded arm of the international trial, the UK cost-utility analysis, and secondary analyses exploring factors associated with health-related quality of life and healthcare costs during 12 month follow-up

AU - the ABLE-UK investigators

AU - Walsh, Tim

AU - Stanworth, Simon

AU - Boyd, Julia

AU - Hope, David

AU - Hemmatpour, Sue

AU - Burrows, Helen

AU - Campbell, Helen

AU - Pizzo, Elena

AU - Swart, Nicholas

AU - Morris, Stephen

PY - 2017/10/31

Y1 - 2017/10/31

U2 - 10.3310/hta21620

DO - 10.3310/hta21620

M3 - Article

SN - 1366-5278

VL - 21

JO - Health Technology Assessment

JF - Health Technology Assessment

IS - 62

ER -

the ABLE-UK investigators. The Age of Blood Evaluation randomised controlled trial (ABLE): Description of the UK funded arm of the international trial, the UK cost-utility analysis, and secondary analyses exploring factors associated with health-related quality of life and healthcare costs during 12 month follow-up. Health Technology Assessment. 2017 Oct 31;21(62). doi: 10.3310/hta21620

The Age of Blood Evaluation randomised controlled trial (ABLE): Description of the UK funded arm of the international trial, the UK cost-utility analysis, and secondary analyses exploring factors associated with health-related quality of life and healthcare costs during 12 month follow-up

Access to Document

Projects

THE AGE OF BLOOD EVALUATION STUDY (ABLE)

Profiles

Timothy Walsh

Cite this